Introduction to EHA Webcast
2008-06-12 - English

Impact of serum free light chain evaluation in monoclonal gammopathy
2008-06-13 - English

Imatinib resistance: the role of BCR-ABL dependent and BCR-ABL independent mechanisms in the loss of response to tyrosine kinase inhibitors
2008-06-13 - English

Targeted inhibition of the BCR-ABL kinase by imatinib has revolutionized the therapy of CML inducing high rates of complete haematological and cytogenetic responses in chronic phase CML patients. However, imatinib has proven less successful in treating CML advanced phases...(more)

Autoimmune neutropenia
2008-06-13 - English

Genes and proteins mediating drug resistance in acute lymphoblastic leukemia
2008-06-13 - English

Using novel targeted drug therapy for front-line management of pediatric acute leukemia
2008-06-13 - English

The role of new agents in the management of chronic myeloid leukemia
2008-06-13 - English

Current aspects of the clinical management of hemolytic disease of the newborn and fetus
2008-06-13 - English

Characteristics and management of patients with very high risk childhood acute lymphoblastic leukemia
2008-06-13 - English

Chronic idiopathic neutropenia: clinical and pathophysiologic aspects
2008-06-13 - English

Prognostic markers in chronic lymphocytic leukemia
2008-06-13 - English

Hemostasis and cancer
2008-06-13 - English

Until recently, the well-known increased risk for venous thromboembolism (VTE) in patients with cancer has been considered an epiphenomenon – not causally related to the transforming malignant events. While it remains true that the pathophysiology of thrombosis in cancer...(more)

Clues on the origin and behaviour of chronic lymphocytic leukemia cells
2008-06-13 - English

Molecular mechanisms of transformation and leukemogenesis by BCR-ABL
2008-06-13 - English

Congenital platelet disorders
2008-06-13 - English

Immunopathogenesis, immunomodulation and management of immune thrombocytopenic purpura in children
2008-06-13 - English

Definition, diagnosis of childhood ITP, pathognesis of ITP, therapeutic immunomodulation of ITP, platelet stimulation by thrombopoietin receptor analoga, clinical presentation and practical management of ITP, todays clinical research by the intercontinental cooperative ITP study group.

Pathogenesis and therapeutic targets in myelodysplastic syndromes
2008-06-13 - English

Allogeneic transplants and immune intervention in multiple myeloma
2008-06-13 - English

Defining the role of epigenetic therapy in myelodysplastic syndromes
2008-06-13 - English

Treating diffuse large B-cell lymphoma: optimizing the use of anti-CD20 antibodies
2008-06-13 - English

Management of immune thrombocytopenic purpura in adults
2008-06-13 - English

Cellular therapy to rebuild immunity after stem cell transplantation
2008-06-13 - English

Targeted therapy of diffuse large cell lymphoma
2008-06-13 - English

Hodgkin lymphoma in the elderly: current status and future directions
2008-06-13 - English

An overview of the current status of management of Hodgkin lymphoma in patients over 60 years.

Biology of Hodgkin lymphoma
2008-06-13 - English

Immunomodulatory drugs (IMiDs) in myelodysplastic syndromes: long-term outcome
2008-06-13 - English

Stratified management of essential thrombocythemia and polycythemia vera
2008-06-13 - English
to be announced!

Major causes of morbidity and mortality in polycythemia vera (PV) and essential thrombocythemia (ET) are represented by thrombosis, bleeding, progression to myelofibrosis and transformation to acute leukemia. Myelosuppressive therapy, preferentially with hydroxyurea, can...(more)

Frontline treatment in multiple myeloma patients ineligible for stem cell transplantation
2008-06-13 - English
to be announced!

Immunological and clinical aspects of double cord blood transplants
2008-06-13 - English

Umbilical cord blood (UCB) has been increasingly used as a source of hematopoietic stem cells for transplantation of children and adults, with malignant and nonmalignant disease, in the myeloablative and in the nonmyeloablative setting. However, the cell dose of a single...(more)

Welcome to the 13th congress of EHA
2008-06-13 - English

Opening Address
2008-06-13 - English

Chronic myeloid leukemia - yesterday, today and tomorrow
2008-06-13 - English

Presentation EHA-José Carreras Young Investigator Fellowship & EHA Fellowships
2008-06-13 - English

Relationship between academia and pharma
2008-06-14 - English

Biallelic Mutations in The Telomerase Component NHP2 Cause The Premature Ageing Syndrome Dyskeratosis Congenita
2008-06-14 - English

IFN-A Promotes Proliferation of Dormant HSCs in vivo, Making Them Susceptible to Elimination by Chemotherapy
2008-06-14 - English

Signature-based approaches to leukemia discovery
2008-06-14 - English

Molecular pathogenesis of B cell lymphomas
2008-06-14 - English

Microparticles, thrombosis and cancer
2008-06-15 - English

Thromboembolic disease is a well recognized complication of cancer. Patients with cancer experience venous thromboembolic events at a rate 4 to 7 times higher than that of the general population. An analysis of the association of venous thromboembolic disease and cancer...(more)

Stem cells in pre leukemia and leukemia
2008-06-15 - English

Chronic lymphoid leukemia - current concepts of molecular pathogenesis and therapy
2008-06-15 - English

There has been tremendous progress in understanding of the biology of chronic lymphocytic leukemia (CLL). At the initiation of the disease, an immortalized, marginal zone, CD5 positive B-cell is the result of a deletion of a limited region on chromosome 13. This cell may be...(more)